Barron's Logo

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

https://www.barrons.com/articles/gsk-stock-price-rsv-vaccine-cdc-626dd5a1

GSK’s RSV Vaccine Could Be Effective for Longer. What That Means.

By
Josh Nathan-Kazis
  • Order Reprints
  • Print Article

Big pharma companies like GSK and Pfizer  are rushing to bring respiratory syncytial virus, or RSV, vaccines to market this year. GSK released data Wednesday that raises questions about the long-term revenue expectations for these shots.

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.